MB
MPM BioImpact Portfolio holdings
AUM
$577M
This Quarter Return
-21.01%
1 Year Return
+8.33%
3 Year Return
+241.63%
5 Year Return
+127.38%
10 Year Return
–
AUM
$609M
AUM Growth
+$609M
(-24%)
Cap. Flow
+$16.7M
Cap. Flow
% of AUM
2.74%
Top 10 Holdings %
Top 10 Hldgs %
91.9%
Holding
14
New
1
Increased
–
Reduced
4
Closed
–
Top Buys
| 1 |
Werewolf Therapeutics
HOWL
|
$41.6M |
Top Sells
| 1 |
Repare Therapeutics
RPTX
|
$12.3M |
| 2 |
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
|
$9.73M |
| 3 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
$2.52M |
| 4 |
iTeos Therapeutics
ITOS
|
$435K |
Sector Composition
| 1 | Healthcare | 95.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cullinan Oncology
CGEM
$445M
| $204M | 33.48% | 7,913,887 | – | – |
|
|
2
iTeos Therapeutics
ITOS
| $60M | 9.85% | 2,338,581 -16,976 | -0.7% | -$435K |
|
|
TCRR
3
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $55.3M | 9.09% | 3,370,982 | – | – |
|
|
4
Repare Therapeutics
RPTX
$71.7M
| $52.3M | 8.59% | 1,676,087 -393,662 | -19% | -$12.3M |
|
|
HARP
5
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $44.3M | 7.28% | 3,196,707 -701,715 | -18% | -$9.73M |
|
|
6
Werewolf Therapeutics
HOWL
$59.9M
| $41.6M | 6.84% | +2,388,011 | New | +$41.6M |
|
|
ONCR
7
DELISTED
Oncorus, Inc.
ONCR
| $32.8M | 5.39% | 2,377,031 | – | – |
|
|
TPTX
8
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $21M | 3.45% | 269,186 | – | – |
|
|
EPZM
9
DELISTED
Epizyme, Inc
EPZM
| $19.4M | 3.18% | 2,331,534 | – | – |
|
|
GTHX
10
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $17.8M | 2.93% | 812,794 -115,000 | -12% | -$2.52M |
|
11
Merus
MRUS
$4.98B
| $14.8M | 2.43% | 700,879 | – | – |
|
12
Y-mAbs Therapeutics
YMAB
$388M
| $11.4M | 1.87% | 337,291 | – | – |
|
13
ADC Therapeutics
ADCT
$345M
| $5.31M | 0.87% | 218,027 | – | – |
|